Do pharma and biotech investors encourage companies indulging in ‘patent thicket?’ This question recently grabbed media headlines. On April 02, 2019, one such report brought out: AbbVie investors are calling for the Chair-CEO power split, flagging the CEO’s USD 4 million bonus payout, fueled … Continue reading
Tag Archives: 3d
Dawns A New Era: Regenerative Medicine For Degenerative Disease
Could breakthrough innovation in ‘Regenerative Medicine’ significantly reduce the need of expensive lifelong medications, or even make the use of some important medical devices less relevant, or even help avoiding expensive and risky surgical interventions? The common answer to these … Continue reading
At The Indian IPR Front: ‘Ground Control, There’s No Major Storm’
The incessant pressure of the developing countries on India, from 2005 to date, to include various restrictive conditions in the Indian Patents Act 2005, still continue. This demand spans across the inclusion of even those provisions, which many experts term … Continue reading
Patented Drugs: A Dangerous Pricing Trend Impacting Patient Access
The upcoming trend of jaw dropping high prices for new patented drugs sends a ‘storm signal’ to many stakeholders, especially for its adverse impact on patient access. Even more intriguing, such high and insane prices are being fixed rather arbitrarily, … Continue reading
Leveraging 3D Printing In Pharma, For Cost Containment And Patient-Centricity
Today, although a number of new and state of the art drugs is regularly being developed, and brought to the market at a reasonably rapid pace, their access to the majority of the global population has still remained a huge … Continue reading
3D Printing: An Emerging Game Changer in Pharma Business
On August 3, 2015, Aprecia Pharmaceuticals in the United States took a game changing step towards a new paradigm of the global pharma business. The Company announced that for the first time ever, the U.S. Food and Drug Administration (US FDA) … Continue reading
Indian Patents Act To Prevail Undiluted…Finally
Curiously enough, what a little birdie told me just a couple of weeks ago, very similar to that I read in various media reports even less than a week later. It was related to a somewhat trepidatious national policy in the making on … Continue reading
Playing Hardball, Riding the Horse of ‘Innovation’
Media reports are now abuzz with various stories related to intense pressure being created by Big Pharma on the United States Government to declare India as a ‘Priority Foreign Country’ for initiating ‘Trade Sanctions’. As we know, ‘Priority Foreign Country’ … Continue reading